Article
The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.
International journal of molecular medicine - 1 Jul 2014
Wang Yang, Tan Hailin, Xu Dongxu, Ma Aihui, Zhang Li, Sun Jiabin, Yang Zhaojuan, Liu Yongzhong, Shi Guowei
Abstract excerpt
Strategies for peroxisome proliferator-activated receptor (PPAR) activation or survivin inhibition have potential for cancer therapy. However, whether the combination of these two approaches can be developed as a rational regimen with enhanced efficiency in the inhibition of tumor cells remains to be determined. In this study, the combinatory effect of PPAR-γ agonist and survivin inhibition on bladder cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
